Healthcare provider profile · identity verified

Jose Ricardo Compean, M.D.

Family Practice · MONROE, MI · NPI 1811167513

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	946	245
Amlodipine Besylate	Amlodipine Besylate	798	205
Levothyroxine Sodium	Levothyroxine Sodium	635	165
Rosuvastatin Calcium	Rosuvastatin Calcium	516	150
Losartan Potassium	Losartan Potassium	505	124
Metformin Hcl	Metformin Hcl	433	121
Lisinopril	Lisinopril	388	101
Omeprazole	Omeprazole	259	84
Carvedilol	Carvedilol	196	56
Glimepiride	Glimepiride	191	55
Allopurinol	Allopurinol	188	55
Trazodone Hcl	Trazodone Hcl	185	49
Potassium Chloride	Potassium Chloride	182	52
Metoprolol Succinate	Metoprolol Succinate	180	53
Eliquis	Apixaban	178	34
Simvastatin	Simvastatin	175	45
Tamsulosin Hcl	Tamsulosin Hcl	158	44
Hydrochlorothiazide	Hydrochlorothiazide	137	38
Famotidine	Famotidine	136	42
Pantoprazole Sodium	Pantoprazole Sodium	135	38
Metoprolol Tartrate	Metoprolol Tartrate	134	33
Gabapentin	Gabapentin	129	40
Ozempic	Semaglutide	127	23
Sertraline Hcl	Sertraline Hcl	119	33
Clopidogrel	Clopidogrel Bisulfate	110	24
Buspirone Hcl	Buspirone Hcl	103	26
Furosemide	Furosemide	99	29
Pravastatin Sodium	Pravastatin Sodium	99	26
Benazepril Hcl	Benazepril Hcl	92	25
Paroxetine Hcl	Paroxetine Hcl	92	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	19
Alendronate Sodium	Alendronate Sodium	78	22
Doxycycline Hyclate	Doxycycline Hyclate	75	62
Albuterol Sulfate Hfa	Albuterol Sulfate	74	32
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	74	19
Duloxetine Hcl	Duloxetine Hcl	72	14
Venlafaxine Hcl Er	Venlafaxine Hcl	72	15
Atenolol	Atenolol	70	20
Tramadol Hcl	Tramadol Hcl	70	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	68	14
Prednisone	Prednisone	67	38
Glipizide	Glipizide	63	19
Fluticasone Propionate	Fluticasone Propionate	61	32
Meloxicam	Meloxicam	61	20
Bisoprolol Fumarate	Bisoprolol Fumarate	54	15
Terazosin Hcl	Terazosin Hcl	54	12
Spironolactone	Spironolactone	52	17
Warfarin Sodium	Warfarin Sodium	51	suppressed
Montelukast Sodium	Montelukast Sodium	50	11
Doxazosin Mesylate	Doxazosin Mesylate	49	12
Fenofibrate	Fenofibrate	48	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	13
Donepezil Hcl	Donepezil Hcl	46	16
Ibuprofen	Ibuprofen	46	15
Escitalopram Oxalate	Escitalopram Oxalate	44	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	38
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	14
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Finasteride	Finasteride	37	suppressed
Jardiance	Empagliflozin	37	14
Xarelto	Rivaroxaban	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	32	12
Januvia	Sitagliptin Phosphate	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Lovastatin	Lovastatin	30	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Lorazepam	Lorazepam	29	16
Lansoprazole	Lansoprazole	27	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Amoxicillin	Amoxicillin	24	17
Clonidine Hcl	Clonidine Hcl	24	suppressed
Ezetimibe	Ezetimibe	24	11
Baclofen	Baclofen	23	suppressed
Clonazepam	Clonazepam	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	12
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	15
Sucralfate	Sucralfate	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	14
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	17	14
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Cephalexin	Cephalexin	17	12
Enalapril Maleate	Enalapril Maleate	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Febuxostat	Febuxostat	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Naproxen	Naproxen	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Colchicine	Colchicine	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Pioglitazone-Metformin	Pioglitazone Hcl/Metformin Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Diazepam	Diazepam	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	11	11
Ramipril	Ramipril	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error